Texas Capital Securities initiates Centrus Energy stock with buy rating

Texas Capital Securities initiated coverage of Centrus Energy with a Buy rating and a $151 price target, versus a share price of $98.44; the stock is down 72% over the past year and near its 52-week low. The firm cited Centrus’s domestic enrichment position, $3 billion in contingent LEU and HALEU commitments, and potential demand exceeding capacity, while other analysts flagged capital costs and competition. Centrus also agreed to acquire Westerman Holdings for approximately $116 million and announced a stock-and-warrant offering whose completion and terms remain uncertain.

Analysis

LEU’s strategic scarcity value is real only if it converts into funded, operating capacity and profitable deliveries. The key distinction is between contingent backlog and bankable revenue: customer commitments may not support returns if delivery schedules, pricing, or required capital are unfavorable. The equity-and-warrant offering and cash/equity-funded supplier acquisition sharpen that execution question; near term, dilution and integration uncertainty can outweigh the scarcity narrative. A vertically integrated component supplier could reduce bottlenecks, but it also adds execution risk outside Centrus’s core enrichment operations.

Over 1–3 months, watch offering terms, diluted share count, acquisition integration costs, and any evidence that backlog is converting into firm orders with attractive economics. Over 6–18 months, capacity commissioning and customer deliveries matter more than analyst targets. If supply remains tight, Centrus benefits; if Urenco, Orano, or policy-supported entrants expand capacity faster than expected, scarcity rents could fade. The market may be underpricing long-run strategic optionality after the drawdown, but could still be overvaluing it relative to near-term cash generation. The thesis weakens if funding needs rise, delivery milestones slip, or reported contract economics fail to support expansion.

Key Decisions for Investors

• Avoid treating the low share price or analyst targets as a valuation floor. Wait for the offering’s price, warrant terms, and resulting dilution before sizing exposure.
• Watchlist a staged long in LEU only after financing is settled and management provides verifiable capacity, delivery, and contract-economics milestones; keep initial risk small given execution and funding uncertainty.
• Use the next results and company updates to test backlog quality: firm versus contingent commitments, delivery timing, and required capital. Reduce or reject the thesis if capacity milestones slip or expansion funding materially exceeds what current resources can support.
• Near-term catalyst risk is asymmetric around financing and operating updates; avoid adding ahead of those disclosures unless willing to absorb dilution-driven volatility. Reassess if new supply from established enrichers or policy changes erodes the expected supply constraint.